Global Stem Cells Group announces plans to sign a strategic alliance with BioTrend Turkey, an innovative biotechnology company focused on genetic, biochemistry, molecular biology, biomaterials and stem cell technologies.
MIAMI, Nov. 20, 2017— Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announced plans to sign a strategic alliance with international biotechnology company BioTrend, which services the Turkish health sector.
GSCG’s goals for the alliance are three-fold:
- Organize Turkey’s first International Society for Stem Cell Application (ISSCA) regenerative medicine symposium in April 2018, in Istanbul.
- Host two hands-on regenerative medicine certification training courses per year in Turkey.
- BioTrend will promote and distribute Adimarket regenerative medicine equipment and supplies in the region.
The two-day, hands-on training courses were developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from adipose tissue and bone marrow. Coursework will focus on stem cell technologies and regenerative medicine protocols. Participating physicians learn skills that can be used to treat patients in their practices, and for career advancement.
“This new alliance with BioTrend is a great opportunity to advance the benefits of stem cell medicine in Turkey,” says Global Stem Cells Group CEO Benito Novas. “Turkey’s geographic location bridges Europe and Asia, allowing GSCG to have a widespread influence in establishing our regenerative medicine presence in both Europe and Asia.
“We are excited to work with BioTrend’s innovative team, and move one step closer to establishing Global Stem Cells Group as the leader in regenerative medicine therapies worldwide.”
The alliance is part of Global Stem Cells Group’s push to highlight Turkey’s appeal as a destination for patients seeking stem cell therapies for a variety of conditions.
Stem cell therapies continue to revolutionize the anti-aging aesthetics industry and help improve the quality of life for patients suffering from some chronic conditions.
To learn more about the Global Stem Cells Group Symposium in Istanbul, visit the stemcellconference.org website, email firstname.lastname@example.org, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
BioTrend was established in Cleveland, Ohio, in 2004, and has been serving the Turkish health sector since 2005. As part of the textile and construction company group, BioTrend benefits from the group`s 25 years of international business experience to move forward stronger and more professionally.
BioTrend focuses on genetic, biochemistry, molecular biology, biomaterials and stem cell technologies; the company has introduced a significant number of innovative technologies to the Turkish healthcare industry. The technologies and products which are safe, high technology and proved their quality in the world are marketed and distributed by BioTrend in Turkey.